Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of hypofractionated radiotherapy vs temozolomide in elderly glioblastoma (RPA V–VI)
2009-016813-11Phase 2Active
- Sponsor
- ASST Spedali Civili di Brescia
- Start
- Jan 2010
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of temozolomide in glioblastoma (GBM) (2 arms), sponsored by ASST Spedali Civili di Brescia. Primary endpoints: Time to progression, Quality-adjusted survival (Murray method) and 1 more. Started Jan 2010; status: active.
02
Drugs
temozolomide
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on 2009-016813-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016813-11.